{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T15:14:53Z","timestamp":1769094893661,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T00:00:00Z","timestamp":1706832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000883","name":"University of Bristol","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.vaccine.2024.02.007","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T09:46:37Z","timestamp":1707385597000},"page":"1599-1607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Surveillance of pneumococcal serotypes in adults hospitalised with acute lower respiratory tract infection in Bristol, UK"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3923-1773","authenticated-orcid":false,"given":"Catherine","family":"Hyams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Lahuerta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0821-9202","authenticated-orcid":false,"given":"Christian","family":"Theilacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jade","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0464-9910","authenticated-orcid":false,"given":"David","family":"Adegbite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8997-3225","authenticated-orcid":false,"given":"Serena","family":"McGuinness","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charli","family":"Grimes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Campling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo","family":"Southern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7104-2433","authenticated-orcid":false,"given":"Michael W.","family":"Pride","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Begier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Maskell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Jodar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradford D.","family":"Gessner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Finn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.02.007_b0005","unstructured":"Public Health England. Chapter 25: Pneumococcal. Immunisation against infectious disease: UK Health Security Agency; 2023. p. 13."},{"key":"10.1016\/j.vaccine.2024.02.007_b0010","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","article-title":"Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000\u201317: a prospective national observational cohort study","volume":"18","author":"Ladhani","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.02.007_b0015","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1586\/erv.12.53","article-title":"The fundamental link between pneumococcal carriage and disease","volume":"11","author":"Simell","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2024.02.007_b0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3201\/eid2801.210734","article-title":"Serotype replacement after introduction of 10-valent and 13-valent pneumococcal conjugate vaccines in 10 countries","volume":"28","author":"Hanquet","year":"2022","journal-title":"Europe Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.02.007_b0025","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1183\/09031936.00183614","article-title":"Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia","volume":"45","author":"Rodrigo","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2024.02.007_b0030","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/thoraxjnl-2018-211767","article-title":"Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination","volume":"74","author":"Hanquet","year":"2019","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2024.02.007_b0035","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study","volume":"11","author":"Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.02.007_b0040","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/thoraxjnl-2019-213725","article-title":"Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013\u201318","volume":"75","author":"Pick","year":"2020","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2024.02.007_b0045","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study","volume":"15","author":"Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.02.007_b0050","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.02.007_b0055","doi-asserted-by":"crossref","first-page":"e430","DOI":"10.1093\/cid\/ciaa158","article-title":"Qualification and clinical validation of an immunodiagnostic assay for detecting 11 additional streptococcus pneumoniae serotype-specific polysaccharides in human urine","volume":"71","author":"Kalina","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.02.007_b0060","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1128\/CVI.00064-12","article-title":"Validation of an immunodiagnostic assay for detection of 13 Streptococcus pneumoniae serotype-specific polysaccharides in human urine","volume":"19","author":"Pride","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2024.02.007_b0065","unstructured":"A pan-pandemic respiratory infection surveillance study."},{"key":"10.1016\/j.vaccine.2024.02.007_b0070","doi-asserted-by":"crossref","unstructured":"Ripley BD. The R project in statistical computing. MSOR Connections The newsletter of the LTSN Maths, Stats & OR Network. 2001; 1: 23\u20135.","DOI":"10.11120\/msor.2001.01010023"},{"key":"10.1016\/j.vaccine.2024.02.007_b0075","article-title":"Incidence of community acquired lower respiratory tract disease in Bristol, UK during the COVID-19 pandemic: A prospective cohort study","volume":"21","author":"Hyams","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.vaccine.2024.02.007_b0080","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/cid\/ciab375","article-title":"Expanded analysis of 20 pneumococcal serotypes associated with radiographically confirmed community-acquired pneumonia in hospitalized US adults","volume":"73","author":"Isturiz","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.02.007_b0085","unstructured":"The R Project for Statistical Computing; 2023."},{"key":"10.1016\/j.vaccine.2024.02.007_b0090","unstructured":"UK Health Security Agency. Pneumococcal disease infections caused by serotypes not in Prevenar 13 vaccine. Updated 20 September 2023; 2023."},{"key":"10.1016\/j.vaccine.2024.02.007_b0095","unstructured":"Joint Committee on Vaccination and Immunisation; 2023."},{"key":"10.1016\/j.vaccine.2024.02.007_b0100","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.arbres.2022.12.015","article-title":"Pneumococcal vaccination in adults: what can we learn from observational studies that evaluated PCV13 and PPV23 effectiveness in the same population?","volume":"59","author":"Dunne","year":"2023","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.vaccine.2024.02.007_b0105","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/mi.2016.71","article-title":"Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage","volume":"10","author":"Mitsi","year":"2017","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2024.02.007_b0110","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/cid\/ciy009","article-title":"The impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in the community acquired pneumonia immunization trial in adults (CAPiTA) study","volume":"67","author":"van Deursen","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.02.007_b0115","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3201\/eid2910.230519","article-title":"Serotype distribution and disease severity in adults hospitalized with Streptococcus pneumoniae infection, Bristol and Bath, UK, 2006\u20132022","volume":"29","author":"Hyams","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.02.007_b0120","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/cid\/ciab307","article-title":"The evolution and distribution of pneumococcal serotypes in adults hospitalized with community-acquired pneumonia in Spain using a serotype-Specific Urinary antigen detection test: The CAPA Study, 2011\u20132018","volume":"73","author":"Torres","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.02.007_b0125","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02432-2021","article-title":"A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany","volume":"59","author":"Bahrs","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2024.02.007_b0130","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11010070","article-title":"Prevalence of pneumococcal serotypes in community-acquired pneumonia among older adults in Italy: A multicenter cohort study","volume":"11","author":"Orsi","year":"2022","journal-title":"Microorganisms"},{"issue":"03","key":"10.1016\/j.vaccine.2024.02.007_b0135","article-title":"Characterising long COVID more than 6 months after acute infection in adults; prospective longitudinal cohort study","volume":"2021","author":"Amin-Chowdhury","year":"2021","journal-title":"England medRxiv"},{"key":"10.1016\/j.vaccine.2024.02.007_b0140","doi-asserted-by":"crossref","unstructured":"Ankert J, Hagel S, Schwarz C, Pan K, Wang L, von Eiff C, et al. Streptococcus pneumoniae re-emerges as a cause of community-acquired pneumonia, including frequent co-infection with SARS-CoV-2, in Germany, 2021. ERJ Open Res 2023; 9.","DOI":"10.1101\/2022.12.15.22282988"},{"key":"10.1016\/j.vaccine.2024.02.007_b0145","first-page":"e360","volume":"3","author":"Brueggemann","year":"2021","journal-title":"Health"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2024.02.007_b0150","doi-asserted-by":"crossref","DOI":"10.1136\/thx.2009.121434","article-title":"BTS guidelines for the management of community acquired pneumonia in adults: update 2009","volume":"64","author":"Lim","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2024.02.007_b0155","unstructured":"National Institute for Health and Care Excellence. Pneumonia in adults: diagnosis and management. Clinical guideline [CG191]. Published: 03 December 2014 Last updated: 31 October 2023. 2014."},{"key":"10.1016\/j.vaccine.2024.02.007_b0160","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/1753465817728479","article-title":"Role of Streptococcus pneumoniae infection in chronic obstructive pulmonary disease patients in Italy","volume":"11","author":"Mantero","year":"2017","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.vaccine.2024.02.007_b0165","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1513\/pats.2306029","article-title":"Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon?","volume":"1","author":"Sethi","year":"2004","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.vaccine.2024.02.007_b0170","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.cmi.2018.02.004","article-title":"Aetiology of lower respiratory tract infection in adults in primary care: a prospective study in 11 European countries","volume":"24","author":"Ieven","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2024.02.007_b0175","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/cid\/ciab1051","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine against medically attended lower respiratory tract infection and pneumonia among older adults","volume":"75","author":"Lewnard","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.02.007_b0180","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/infdis\/jiac098","article-title":"Effectiveness of pneumococcal conjugate vaccination against virus-associated lower respiratory tract infection among adults: A case-control study","volume":"227","author":"Lewnard","year":"2023","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.02.007_b0185","doi-asserted-by":"crossref","first-page":"e057464","DOI":"10.1136\/bmjopen-2021-057464","article-title":"Incidence of acute lower respiratory tract disease hospitalisations, including pneumonia, among adults in Bristol, UK, 2019, estimated using both a prospective and retrospective methodology","volume":"12","author":"Hyams","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2024.02.007_b0190","doi-asserted-by":"crossref","first-page":"11865","DOI":"10.1038\/s41598-021-91234-y","article-title":"Prognostic factors for mortality in invasive pneumococcal disease in adult: a system review and meta-analysis","volume":"11","author":"Chen","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2024.02.007_b0195","unstructured":"Gierke R, Wodi AP, Kobayashi M. Pneumococcal disease. Epidemiology and prevention of vaccine-preventable diseases; 2021. p. 279-96."},{"key":"10.1016\/j.vaccine.2024.02.007_b0200","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s40001-021-00539-1","article-title":"Effects of COVID-19 prevention procedures on other common infections: a systematic review","volume":"26","author":"Dadras","year":"2021","journal-title":"Eur J Med Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24001531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24001531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:37:44Z","timestamp":1759405064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24001531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0264410X24001531"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.02.007","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surveillance of pneumococcal serotypes in adults hospitalised with acute lower respiratory tract infection in Bristol, UK","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}